Longevity & Healthspan
GLP-1 leaders, gene-editing platforms, diagnostics-at-scale, biopharma compounders. Demographics writes the demand curve.
Composite Index — since inception (Dec 30, 2025)
Three weighting variants of the same constituent basket, rebased to 1,000 at inception. EW = ticker-equal-weight with quarterly drift. CW = cap-weighted (10% cap; below ten names the cap is infeasible, so the sub-index is equal weight by construction) with semi-annual rebalance. MW = drift-only (1/N at inception, market does the tilting between rebalances). Click a legend entry to toggle its line.
Constituents
Every HALO 100 constituent tagged into this sector. Click a column header to sort (best to worst). Click a row to open the stock detail page in a new tab.
| Ticker | Company | Region | Last | 1d | 1w | 1m | 3m | 6m | 1y | CCY |
|---|---|---|---|---|---|---|---|---|---|---|
| REGN | Regeneron | NAM | 955.47 | +0.45% | +5.65% | +19.98% | +18.55% | +36.84% | +40.50% | USD |
| LLY | Eli Lilly | NAM | 1443.50 | +1.14% | +6.61% | +15.33% | +22.00% | +43.64% | +42.27% | USD |
| GXI.DE | Gerresheimer | EUR | 31.08 | -1.52% | -0.38% | +8.29% | +11.08% | +15.88% | +25.83% | EUR |
| AMGN | Amgen | NAM | 465.67 | -0.30% | +1.14% | +7.29% | +11.04% | +42.71% | +40.43% | USD |
| VKTX | Viking Therapeutics | NAM | 29.22 | +5.95% | +8.87% | +6.76% | -13.11% | -3.47% | -28.35% | USD |
| NVO | Novo Nordisk | EUR | 41.63 | +2.41% | +3.27% | +6.14% | -7.24% | -6.95% | -14.13% | USD |
| VRTX | Vertex Pharma | NAM | 538.60 | -0.74% | -1.55% | +5.87% | +4.47% | +23.26% | +24.05% | USD |
| ZEAL.CO | Zealand Pharma | EUR | 242.00 | +0.37% | +3.91% | +5.49% | -22.34% | -19.20% | -44.46% | DKK |
| NTRA | Natera | NAM | 319.09 | -1.19% | +2.71% | -21.17% | +1.56% | +71.22% | +52.31% | USD |
| ILMN | Illumina | NAM | 207.01 | -1.21% | -2.87% | -22.74% | +7.18% | +45.23% | +69.71% | USD |